Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling

Ciclopirox (CPX) is an antifungal drug that has recently been reported to act as a potential anticancer drug. However, the effects and underlying molecular mechanisms of CPX on glioblastoma multiforme (GBM) remain unknown. Bortezomib (BTZ) is the first proteasome inhibitor-based anticancer drug appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Zhipeng, Han, Shengnan, Jin, Qiumei, Zhou, Ningning, Lu, Junwan, Shangguan, Fugen, Yu, Shiyi, Liu, Yongzhang, Wang, Lu, Lu, Jianglong, Li, Qun, Cai, Lin, Wang, Chengde, Tian, Xiaohe, Chen, Lingyan, Zheng, Weiming, Lu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935936/
https://www.ncbi.nlm.nih.gov/pubmed/33674562
http://dx.doi.org/10.1038/s41419-021-03535-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935936/
https://www.ncbi.nlm.nih.gov/pubmed/33674562
http://dx.doi.org/10.1038/s41419-021-03535-9

Ejemplares similares